Skip to main content

Enanta Pharmaceuticals Inc

ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001177648

No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.

Politicians who traded ENTA

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
1
Filings
1
Politicians
1
Buys / sells
0 / 1
Estimated volume
$8.00K
Sum of range midpoints
Politicians who traded ENTA
PoliticianTradesBuys / sellsEst. volumeLast tradedLast filed
Daniel S. Goldman House · NY
10 / 1$8.00KJul 12, 2023Aug 13, 2023

Trades

Reported trades in Enanta Pharmaceuticals Inc, newest filings first.

Politician trades
PoliticianAssetTypeOwnerTradedFiledDelayAmountSource
Daniel S. Goldman House · NY
ENTAEnanta Pharmaceuticals, Inc.SellSelfJul 12, 2023Aug 13, 202332 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.